New drug targets vitamin D receptors in hormone resistant prostate cancers
Wednesday, November 17, 2010 - 22:30
in Health & Medicine
A new anti-cancer drug aimed at vitamin D receptors on cancer cells has prompted encouraging responses in the levels of PSA (prostate specific antigen) in men with prostate cancer that has become resistant to hormonal therapies.